Taysha Gene Therapies Inc (TSHA) Stock Price, Quote & News

Company Profile

Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for t...

Industry: Biotechnology

Sector: Healthcare

Phone: 214 612 0000

Website: www.tayshagtx.com

Address:

3000 Pegasus Park Drive, Suite 1430, Dallas, United States

Dark_Horse_Investments Sep. 16 at 9:18 PM

$TSHA bit of tumble today. just when we thought that $3 was shaping up to become the new floor.

2 · Reply

highnihilism Sep. 16 at 3:10 PM

Biotech → $VCEL Vericel $XNCR Xencor $KALV Kalvista Pharmaceuticals $VRDN Viridian Therapeutics $TSHA Taysha Gene Therapies

0 · Reply

Quantumup Sep. 12 at 11:47 AM

Citizens reiterated $TSHA Market Outperform-$6 and said, Taysha Gene Therapies is developing TSHA-102 for Rett Syndrome with remarkable impact on developmental milestones. $ALPMY Citizens added:

0 · Reply

King_of_Bio Sep. 11 at 2:10 PM

$TSHA

0 · Reply

quickaspeter Sep. 6 at 3:00 PM

$TSHA “…Taysha’s Board of Directors granted five new employees, in the aggregate, options to purchase 225,000 shares of the Company’s common stock…” https://www.tipranks.com/news/the-fly/taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-thefly-2#google_vignette

0 · Reply

King_of_Bio Sep. 5 at 5:02 PM

$GOSS $AKBA $TSHA $SLS $CMPX Told you guys! $GOSS is flying under the radar and ripping, $TSHA same thing! It's BIO SEASON!

1 · Reply

Doozio Sep. 5 at 3:39 PM

$TSHA out of the tightness. 🐒🍌🧠⏰♾️

0 · Reply

quickaspeter Sep. 4 at 10:42 PM

$TSHA Let’s go!! 💥🚀💰

0 · Reply

Vertical_Capital Sep. 4 at 9:52 PM

$CRMD Deerfield...parlays Melinta Therapeutics buyout from Cormedix...into convertibles and equity at $13.47. THEN, parlays Cormedix BUYOUT at $30-$40 to highest bidder! It's called the GAME! DON'T LET SP FOOL YOU! LOAD UP! $TSHA TOO

1 · Reply

warren5677 Sep. 4 at 9:22 PM

$TSHA Great day with monster volume!! Hopefully she's heading to $5. Thats when the real buying starts (tutes). Once we hit that Astellas could offer $10 (100% premium buyout) or we go alone and see $15-20. I got time on my side. Im hunkered down here until the end. Bottom line is this therapy works, and S. Nolan is the FN man!!

0 · Reply

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 12, 2025, 1:38 PM EDT - 5 weeks ago

Taysha Gene Therapies, Inc. (TSHA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 8:01 AM EDT - 5 weeks ago

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 5, 2025, 4:05 PM EDT - 6 weeks ago

Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12

Jun 3, 2025, 5:17 PM EDT - 3 months ago

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

May 29, 2025, 1:06 PM EDT - 3 months ago

Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?

May 28, 2025, 10:40 PM EDT - 3 months ago

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

May 28, 2025, 4:02 PM EDT - 3 months ago

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

May 28, 2025, 4:01 PM EDT - 3 months ago

Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102

May 15, 2025, 2:07 PM EDT - 4 months ago

Taysha Gene Therapies, Inc. (TSHA) Q1 2025 Earnings Call Transcript

May 15, 2025, 8:00 AM EDT - 4 months ago

Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 4:05 PM EDT - 4 months ago

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

Mar 31, 2025, 2:25 PM EDT - 6 months ago

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

BNTX NVAX SLDB SRPT XBI

Feb 26, 2025, 2:54 PM EST - 7 months ago

Taysha Gene Therapies, Inc. (TSHA) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 8:00 AM EST - 7 months ago

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

Feb 19, 2025, 8:00 AM EST - 7 months ago

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Jan 27, 2025, 7:53 PM EST - 8 months ago

Taysha Gene Therapies Is Showing Promise For Rett Syndrome

Nov 14, 2024, 8:25 AM EST - 10 months ago

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

AAP

Nov 13, 2024, 10:48 PM EST - 10 months ago

Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 10 months ago

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 22, 2024, 8:00 AM EDT - 11 months ago

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

Oct 14, 2024, 12:55 AM EDT - 1 year ago

Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data

Aug 12, 2024, 12:08 PM EDT - 1 year ago

Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Jun 26, 2024, 7:36 AM EDT - 1 year ago

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

GIS

Jun 18, 2024, 11:42 AM EDT - 1 year ago

What's Going On With Taysha Gene Therapies Stock Tuesday?

Jun 18, 2024, 7:30 AM EDT - 1 year ago

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Jun 12, 2024, 7:00 AM EDT - 1 year ago

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

May 15, 2024, 4:55 AM EDT - 1 year ago

Taysha Gene Therapies, Inc. (TSHA) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:01 PM EDT - 1 year ago

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 7, 2024, 4:05 PM EDT - 1 year ago

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

May 2, 2024, 8:00 AM EDT - 1 year ago

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

Mar 20, 2024, 12:30 PM EDT - 1 year ago

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts

Mar 19, 2024, 9:04 PM EDT - 1 year ago

Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript

Mar 19, 2024, 4:01 PM EDT - 1 year ago

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Mar 14, 2024, 4:26 PM EDT - 1 year ago

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19

Feb 29, 2024, 8:00 AM EST - 1 year ago

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

Feb 15, 2024, 4:01 PM EST - 1 year ago

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

Jan 22, 2024, 8:00 AM EST - 1 year ago

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

Jan 10, 2024, 8:00 AM EST - 1 year ago

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Dec 19, 2023, 7:30 AM EST - 1 year ago

Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies

TRIN

Nov 29, 2023, 8:00 AM EST - 1 year ago

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

Nov 14, 2023, 9:53 PM EST - 2 years ago

Taysha Gene Therapies, Inc. (TSHA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:08 PM EST - 2 years ago

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Nov 7, 2023, 8:00 AM EST - 2 years ago

Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14

Nov 3, 2023, 7:41 PM EDT - 2 years ago

Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy'

Oct 24, 2023, 8:00 AM EDT - 2 years ago

Taysha Gene Therapies Presents New Preclinical In-vitro Data on TSHA-102 in Rett Syndrome Supporting miRARE Regulation of MECP2 Expression at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

Oct 10, 2023, 8:00 AM EDT - 2 years ago

Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

Sep 26, 2023, 8:00 AM EDT - 2 years ago

Taysha Gene Therapies Announces Second Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Adult Trial for the Treatment of Rett Syndrome

Dark_Horse_Investments Sep. 16 at 9:18 PM

$TSHA bit of tumble today. just when we thought that $3 was shaping up to become the new floor.

2 · Reply

highnihilism Sep. 16 at 3:10 PM

Biotech → $VCEL Vericel $XNCR Xencor $KALV Kalvista Pharmaceuticals $VRDN Viridian Therapeutics $TSHA Taysha Gene Therapies

0 · Reply

Quantumup Sep. 12 at 11:47 AM

Citizens reiterated $TSHA Market Outperform-$6 and said, Taysha Gene Therapies is developing TSHA-102 for Rett Syndrome with remarkable impact on developmental milestones. $ALPMY Citizens added:

0 · Reply

King_of_Bio Sep. 11 at 2:10 PM

$TSHA

0 · Reply

quickaspeter Sep. 6 at 3:00 PM

0 · Reply

King_of_Bio Sep. 5 at 5:02 PM

$GOSS $AKBA $TSHA $SLS $CMPX Told you guys! $GOSS is flying under the radar and ripping, $TSHA same thing! It's BIO SEASON!

1 · Reply

Doozio Sep. 5 at 3:39 PM

$TSHA out of the tightness. 🐒🍌🧠⏰♾️

0 · Reply

quickaspeter Sep. 4 at 10:42 PM

$TSHA Let’s go!! 💥🚀💰

0 · Reply

Vertical_Capital Sep. 4 at 9:52 PM

1 · Reply

warren5677 Sep. 4 at 9:22 PM

0 · Reply

wwmeinc Sep. 4 at 8:33 PM

$TSHA .....I have consolidation on the mind in this space/sector....just as $RNA might or might not have a suitor or two kicking the tires(I am in the latter camp though and believe those biotech's showing good clinical data and with that all important safety screening coming to the top, will get real offers)...Hedge fund RTW Investments has position themselves squarely in the middle....in my view though...after the SRPT safety fiasco....DMD is all about what is safe and w/o any questions...with today's abnormally high vol.,over 14.2M shrs...maybe the shares have 'finally' once and for all left the $2.00's behind...onwards to the $4.00's and beyond ;) Eternal optimist! Good trading and glta https://whalewisdom.com/stock/tsha

0 · Reply

Beagan Sep. 4 at 8:30 PM

$TSHA

0 · Reply

King_of_Bio Sep. 4 at 7:06 PM

$TSHA Don't you DARE try and persuade us to join your shyt-stock! I will block your azz from here to Mexico and beat you like a piñata you little shyt!!! Go away!!!

1 · Reply

ConstanceAtkeson887 Sep. 4 at 4:48 PM

$TSHA is developing therapies, but investor certainty is years away. AITX is delivering now and pledging no reverse split through 2026. https://finance.yahoo.com/news/aitx-extends-no-reverse-split-124000711.html

0 · Reply

bmjmj1 Sep. 4 at 4:23 PM

$TSHA

0 · Reply

King_of_Bio Sep. 4 at 3:42 PM

$TSHA Only greenie in my portfolio today. Love this company!

0 · Reply

mds04086 Sep. 4 at 3:31 PM

$TSHA I love TSHA

0 · Reply

quickaspeter Sep. 4 at 2:56 PM

$TSHA Will TSHA be participating in WMS or EANO 2025 Congress?

0 · Reply

warren5677 Sep. 4 at 2:55 PM

$TSHA TSHA Bulls LFG!!

1 · Reply

King_of_Bio Aug. 28 at 1:45 PM

$CMPX $GOSS $TSHA $AKBA Bio stocks you rarely ever hear about that are doing VERY well and will make shareholders VERY wealthy in years to come. If you know, you know. Good luck all - it's ALWAYS bio season.

2 · Reply

jjmstocks1 Aug. 24 at 12:26 PM

$TSHA +62% on the year .. biotech name finishing off with an inside week .. like how these were able to push off of the 10-ema and go higher ..

0 · Reply

Dark_Horse_Investments Aug. 23 at 11:26 PM

$TSHA Well lets see if this time we leave the highs $2 for good and let $3 be the new floor & base...

0 · Reply

Market Cap	837.48M
Revenue (ttm)	8.33M
Net Income (ttm)	-89.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,072.03%
Debt to Equity Ratio	0.17

Volume	2,937,200
Avg Vol	3,118,436
Day's Range	N/A - N/A
Shares Out	272.80M
Stochastic %K	2%
Beta	0.98
Analysts	Strong Sell
Price Target	$8.67